Skip to content

Child and Adolescent Psychiatry and Mental Health

ISSN 1753-2000

10 papers in the library · 114 citations · publishing 2013-2026

Papers

Sort Most recent Most cited

The effect of mindfulness-based stress reduction (MBSR) Training on emotion regulation during voluntary inpatient care for youth with mixed mental health conditions

Child and Adolescent Psychiatry and Mental Health October 23, 2026 Fan Peng, Andrea T. Shafer, Sunita Vohra et al.

Adolescence is a sensitive period for emotional and cognitive development, with heightened risk for mental health challenges, particularly in individuals with ADHD and affective disorders. While Mindfulness-Based Stress Reduction (MBSR) improves emotion regulation and cognition in healthy populations, its effects in clinically complex adolescents are less understood. This pilot randomized...

Follow-up effects of mindfulness-based interventions on anxiety in adolescents: a systematic review and meta-analysis of randomized controlled trials.

Child and Adolescent Psychiatry and Mental Health July 5, 2026 Hongbo Zhao, Hongxin Huang

Anxiety is one of the most prevalent mental health problems in adolescence, and its onset often coincides with the secondary school years. Mindfulness-based interventions (MBIs) have shown short-term benefits for reducing anxiety in young people, but the durability of these benefits after treatment remains uncertain. To inform clinical and school-based practice, a quantitative synthesis focused...

The renaissance of research on psychedelics in child and adolescent psychopharmacology

Child and Adolescent Psychiatry and Mental Health March 13, 2026 Marc-Antoine Crocq, Philippe Auby

Aims The recent regulatory approval of esketamine in adults heralded the renaissance of research into psychedelic compounds. However, the relevance of this resurgence for children and adolescents remains unclear. This review examines the rationale for investigating psychedelics in pediatric psychopharmacology. Methods We reviewed recent literature, regulatory documents, and clinical trial...

Toward a framework for psychedelic clinical trials in adolescents

Child and Adolescent Psychiatry and Mental Health March 10, 2026 Christine K. Moore, Henry Riordan, Rolana Avrumson et al. 1 citation

Recent clinical trials conducted by both industry and academic institutions have demonstrated the therapeutic potential of psychedelics for a variety of mental health conditions in adults. Considering the neurodevelopmental aspects of many of these disorders and the widespread occurrence of these conditions among younger individuals, there is increasing interest in exploring the potential for...

DOI: 10.1186/s13034-026-01064-x (opens in new tab) Clinical trial Population Dialog box Regulatory science +11

Unusual experiences and early-onset psychosis associated to hallucinogen use in adolescents: a systematic review and meta-analysis

Child and Adolescent Psychiatry and Mental Health March 8, 2026 Maite Armanino-Irigaray, Ana Catalán, Claudia Aymerich et al. 1 citation

BACKGROUND: Hallucinogen use among adolescents is increasing worldwide. In this context, in recent years, hallucinogens have re-emerged in scientific and public discourse. However, whether there is an association between hallucinogens use in adolescents and the impact of such use in individuals with Early-Onset Psychosis (EOP), remains unclear. This systematic review and meta-analysis evaluated...

DOI: 10.1186/s13034-026-01060-1 (opens in new tab) Psychosis Forensic psychiatry Hallucinogen Medline +2

Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits.

Child and Adolescent Psychiatry and Mental Health February 24, 2026 David Sjöström, Emma Claesdotter-Knutsson, Petri Kajonius

BACKGROUND: Adolescents are increasingly using classical psychedelics, yet little is known about how psychedelics use is related to their mental health. Emerging evidence suggests that adolescents may be more vulnerable to adverse outcomes in relation to psychedelic use compared to adults. This descriptive and exploratory study examined differences between adolescents and adults in reported...

DOI: 10.1186/s13034-026-01048-x (opens in new tab) Full text (opens in new tab) Adolescents Adverse outcomes Personality traits Psychedelics

Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents.

Child and Adolescent Psychiatry and Mental Health June 4, 2025 Sarah Forsberg, Amanda E. Downey, Lindsey D Bruett et al. 5 citations

Psychedelic-assisted therapy (PAT) is gaining recognition as a promising intervention for treatment-refractory mental health conditions in adults. While interest in its applications for adolescents is growing, critical gaps remain in understanding safe and effective delivery of PAT to this vulnerable population, including implications for caregiver/family (used interchangeably) involvement in...

Substance use in sexual minority youth: prevalence in an urban cohort.

Child and Adolescent Psychiatry and Mental Health September 16, 2023 Florian Vock, Lydia Johnson-Ferguson, Laura Bechtiger et al. 3 citations

Little comparative data on substance use (SU) between sexual minority youth (SMY) and heterosexual youth (HET) is available. This study compares the prevalence of SU in an urban cohort between SMY and HET and evaluates demographic and psychosocial predictors of SU. Data came from a prospective-longitudinal cohort study in an urban setting (N = 1297). SU and psychosocial variables such as...

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial

Child and Adolescent Psychiatry and Mental Health September 14, 2023 Xiaofeng Lan, Chengyu Wang, Fan Zhang et al. 22 citations

BACKGROUND: Ketamine and its enantiomer have rapid and robust effects on depressive symptom and suicidal ideation. Little is known about their cognitive effects in adolescents. We aimed to evaluate the short-term effect of esketamine on cognition in adolescents with major depressive disorder (MDD) and suicidal ideation. METHOD: In this randomized-controlled trial, 51 participants aged 13-18...

Brain and self – a neurophilosophical account

Child and Adolescent Psychiatry and Mental Health 2013 Georg Northoff 82 citations

We have experience and are conscious of the world. Who though is conscious? This is the subject or self of experience. While in the past the concept of self has been matter of philosophical discussion, psychoanalysis shifted it into the domain of psychology where it surfaced as ego. More recently, brain imaging allows to investigate the neural mechanisms underlying our subjective experience of...

DOI: 10.1186/1753-2000-7-28 (opens in new tab) Self Relevance law Subject documents Subject matter +4